Evidence map›Paper›PMID 38726890›Full record

ArticleInternational journal of methods in psychiatric research2024

Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study.

Salma Mawfek Khaled, Nour W Z Alhussaini, Majid Alabdulla, Nancy A Sampson, Ronald C Kessler, Peter W Woodruff, Sheik Mohammed Al-Thani

Abstract read
In one paragraph

Article in International journal of methods in psychiatric research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Closing the gaps in mental health epidemiology-New survey data from Qatar.International journal of methods in psychiatric research · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Salma Mawfek KhaledDepartment of Population Medicine, College of Medicine, Qatar University, Doha, Qatar.ORCID 0000-0002-8844-3441
Nour W Z AlhussainiDepartment of Population Medicine, College of Medicine, Qatar University, Doha, Qatar.
Majid AlabdullaDepartment of Psychiatry, Hamad Medical Corporation, Doha, Qatar.
Nancy A SampsonDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
Ronald C KesslerDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-4831-2305
Peter W WoodruffSchool of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Sheik Mohammed Al-ThaniDepartment of Public Health, Ministry of Public Health, Doha, Qatar.

Funding

Hamad Medical Corporation Qatar through Cambridgeshire and Peterborough NHS Foundation Trust UK 0XS0002
6 · The paper itself

Abstract

objectivesTo estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time.

methodsWe conducted a national phone survey of 5,195 Qatari and Arab residents in Qatar (2019-2022) using the Composite International Diagnostic Interview Version 3.3 and estimated lifetime mood and anxiety defined diagnoses. Survival-based discrete time models, lifetime morbid risk, and treatment projections were estimated.

resultsLifetime prevalence of any disorder was 28.0% and was associated with younger cohorts, females, and migrants, but lower formal education. Treatment contact in the year of disorder onset were 13.5%. The median delay in receiving treatment was 5 years (IQR = 2-13). Lifetime treatment among those with a lifetime disorder were 59.9% for non-healthcare and 63.5% for healthcare; it was 68.1% for any anxiety and 80.1% for any mood disorder after 50 years of onset. Younger cohorts and later age of onset were significantly predictors of treatment.

conclusionsLifetime prevalence of mental disorders in Qatar is comparable to other countries. Treatment is significantly delayed and delivered largely in non-healthcare sectors thus the need for increased literacy of mental illness to reduce stigma and improve earlier help-seeking in healthcare settings.

Indexed as

Anxiety DisordersMood DisordersAdolescentAdultAgedFemaleHumansMaleMiddle AgedPrevalenceQatarYoung Adult5th edition (DSM‐5)diagnostic and statistical manuallifetime prevalencelifetime treatmentmental disorderQatar

Identifiers

PMID38726890
PMCPMC11323770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.